KN510713

KN-510713 · New Cancer Cure-Bio Co.,Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KN510713, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: The KN510713 Study in Combination With mFOLFIRINOX [Phase 1, Phase 2]